FibroScan^® GO Now Available in the UK

Chronic liver disease is a public health crisis that affects 1.9 billion people worldwide and counts for two million deaths¹ per year. The main causes of chronic liver disease include nonalcoholic fatty liver disease (NAFLD) and its more severe form nonalcoholic steatohepatitis (NASH), alcohol and viral hepatitis.

To help battle this growing public health crisis, Echosens has launched FibroScan^® GO, an affordable, cost-effective tool for screening liver health, improving liver health management at the point of care for primary care practices and reducing the flow of patients in secondary care centers.

FibroScan^® GO is a solution for quickly and easily assessing liver stiffness, using LSM by VCTE™ and CAP™ for liver fibrosis and steatosis assessment and management among patients with, or suspected of having, liver fibrosis and cirrhosis. 

FibroScan^® GO Benefits

Primary care practices can now manage and monitor at-risk patients and make an early diagnosis, which is essential for halting or reversing liver disease. As the gold standard non-invasive solution, FibroScan^® technology is supported by 3000+ peer reviewed publications and 140+ guidelines. This powerful tool for the prognosis of disease course enables immediate medical decisions for improved patient outcomes and higher healthcare efficiency.

FibroScan^® GO enables operators to screen at-risk patients for early intervention and diagnosis, patient stratification and monitoring of disease progression. Also, this fast, simple and non-invasive examination can be performed by any trained operator, including healthcare practitioner or nurse. The test is repeatable and reproducible and offers consistent results.

FibroScan^® GO’s Key Features

For busy practices, FibroScan^® GO integrates instantly into an office-based practice with small footprint and connectivity. What’s more, this tool is small and mobile so that it can be easily integrated outside of secondary care to enhance clinical decision support with the Interpretation Guide and Scores by Echosens. Available on myFibroScan app, FibroScan^® GO offers centralized and secure data management with Echosens Cloud.

We are proud to bring greater peace of mind with FibroScan^® GO’s proactive and dedicated support team who assist with onsite installation and training. With a flexible and affordable pay-per-exam offer, this tool not only reduces referrals to secondary care, but also eliminates the need for capital investment to achieve an early liver disease diagnosis that reduces the cost of liver-related illness.

References: 

1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26. PMID: 30266282.